Earnings Release • Nov 11, 2013
Earnings Release
Open in ViewerOpens in native device viewer
News Details
Corporate | 11 November 2013 07:30
MeVis Medical Solutions AG: MeVis’ leap in sales and profits in the third quarter
MeVis Medical Solutions AG / Key word(s): Quarter Results/Interim Report
11.11.2013 / 07:30
Accumulated revenues exceed previous year by 9 % because of a very strong third quarter
Bremen, November 11, 2013 – Today, MeVis Medical Solutions AG [ISIN: DE000A0LBFE4], a leading software provider for the medical imaging market, announced its results for the first three quarters of 2013.
Sales in the third quarter of 2013 came to EUR 4,210 k, up a considerable 30 % on the third quarter of 2012 (prev. year. EUR 3,235 k). Sales in the first nine months of 2013 totaled EUR 11,072 k, which is an increase of 9 % year on year (prev. year: EUR 10,113 k). Maintenance and service revenues rose once again by 3 % to EUR 4,615 k (prev. year: EUR 4,499 k) and account for 42 % of total sales (prev. year: 44 %). License sales even increased by 10 % to EUR 5,773 k (prev. year: EUR 5,257 k). Higher grants for development costs and maintenance have also contributed to sales in 2013.
Sales in the Digital Mammography segment increased considerably by 11 % to EUR 8,516 k (prev. year: EUR 7,694 k). Sales in the Other Diagnostics segment also increased, by 6 % to EUR 2,556 k (prev. year: EUR 2,419 k).
Capitalized development expenses were almost halved in the first nine months of 2013, falling by 44 % year on year to EUR 1,075 k (prev. year: EUR 1,908 k).
Operating costs in the third quarter of 2013 were up slightly on the prior-year quarter; however, operating costs in the first nine months of 2013 are still down significantly year on year. Personnel expenses amounted to EUR 1,963 k, up 7 % on the prior-year quarter. For the first three quarters, this corresponds to a total drop of 7 %. Other operating expenses amounted to EUR 485 k in the third quarter, which corresponds to an increase of 11 % on the prior-year quarter. However, for the first three quarters of 2013, this also represents a drop of 12 %.
Depreciation and amortization came to EUR 1,596 k (down 32 % year on year), resulting in EBIT (earnings before interest and taxes) of EUR 3,162 k (up a significant 62 % on the prior-year figure of EUR 1,951 k) and an EBIT margin of 29 % (prev. year: 19 %).
With a financial result of EUR -107 k and very low income tax expenses, the first nine months of 2013 closed on a very positive note, with consolidated net profit of EUR 2,949 k (prev. year: EUR 472 k). This resulted in earnings per share of EUR 1.71 (prev. year: EUR 0.27).
Cash and cash equivalents also increased in the third quarter of 2013 and amounted to EUR 11,714 k as of September 30, 2013 (compared to EUR 8,665 k as of December 31, 2012).
‘Based on the performance so far, on November 4th, we once again raised our forecast for 2013. We currently anticipate that sales for fiscal year 2013 will be higher than the level in fiscal year 2012. In addition, we expect consolidated earnings before interest and taxes (EBIT) well above the prior-year figure and a positive cash flow from operating activities.’ said Dr. Robert Hannemann, CFO of MeVis Medical Solutions AG.
‘Following the completion of the consolidation measures, we continue to focus heavily on the development and implementation of measures designed to generate future sales growth, where we can already see the first project successes.’ added Marcus Kirchhoff, CEO of MeVis Medical Solutions AG. ‘We will, at the end of this year, launch first services, such as the MeVis Online Academy and MeVis Online CAD as part of our business with internet-based services. Furthermore, due to increased customer requirements for existing products we will, for the first time again, increase our resources in the coming quarters.’
The financial reports of the company can be downloaded here: http://www.mevis.de/ir_finanzberichte.html
End of Corporate News
11.11.2013 Dissemination of a Corporate News, transmitted by DGAP – a company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
DGAP’s Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
| Language: | English |
| Company: | MeVis Medical Solutions AG |
| Caroline-Herschel-Str. 1 | |
| 28359 Bremen | |
| Germany | |
| Phone: | +49 421 224 95 0 |
| Fax: | +49 421 224 95 999 |
| E-mail: | [email protected] |
| Internet: | http://www.mevis.de |
| ISIN: | DE000A0LBFE4 |
| WKN: | A0LBFE |
| Listed: | Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, München, Stuttgart |
| End of News | DGAP News-Service |
| - - - |
| 238928 11.11.2013 |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.